BioSpace News Archive

Press Releases

Sironax Advances Enrollment in Phase 2 FORGE-LM Obesity Trial of NAMPT Activator SIR4156

October 13, 2026
·
3 min read
Press Releases

Triveni Bio Doses First Patient in Global Phase 2 Proof-of-Concept Study of TRIV-573 in Atopic Dermatitis and Provides I&I Pipeline Update

October 13, 2026
·
3 min read
Press Releases

Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026

October 13, 2026
·
1 min read
Press Releases

Kelun-Biotech to Present Multiple Study Results at ESMO 2026

October 13, 2026
·
7 min read
Press Releases

Paragon Labs Expands Leadership Team with Former Apogee Executives; Velaris Therapeutics Acquired by Alaunos Therapeutics, Inc.

October 13, 2026
·
4 min read
Press Releases

Rhode Island Life Science Hub and Cognito Therapeutics Launch Brain Health Collaboratory to Advance Innovation in Alzheimer’s Disease

October 13, 2026
·
6 min read
Press Releases

NEW TWICE-YEARLY MAINTENANCE DOSING OPTION FOR PEOPLE LIVING WITH GENERALIZED MYASTHENIA GRAVIS IN CANADA

October 13, 2026
·
12 min read
Press Releases

Hiteck Licenses Investigational Next-Generation NGF Eye Drop HT006.2.2 to Visara for Neurotrophic Keratitis Outside Greater China

October 13, 2026
·
7 min read
Press Releases

Sitryx Reports Positive Phase 1b Results for First-in-Class Oral PKM2 Modulator SYX-5219 in Patients with Moderate to Severe Atopic Dermatitis

October 13, 2026
·
6 min read
Press Releases

Paul J. Diaz Elected to Merck & Co., Inc., Rahway, N.J., USA Board of Directors

October 13, 2026
·
3 min read